Generic Drugs/Biosimilars

Feb 14, 2017
By Pharmaceutical Technology Editors
Aurobindo has added four cell-culture derived biosimilars to its product line.
Feb 08, 2017
By Pharmaceutical Technology Editors
Dr. Reddy’s has expanded its commercial operations in Europe with the introduction of its range of generic drugs in France.
Jan 27, 2017
By Pharmaceutical Technology Editors
The agency recommended approval of a total of eight drugs at its January 2017 meeting, two of which are biosimilars.
Dec 19, 2016
By Pharmaceutical Technology Editors
A pilot project, beginning in 2017, will support the development of biosimilars.
Nov 02, 2016
The biosimilar pathway permits licensure based on less than full clinical data.
Nov 02, 2016
Pharmaceutical Technology
Reliable, high-quality products require innovative analytics and production.
Oct 04, 2016
By Pharmaceutical Technology Editors
Xellia added laboratory space and personnel in Zagreb, Croatia to work on anti-infective products that combat the antimicrobial resistance problem.
Sep 30, 2016
By Pharmaceutical Technology Editors
Ravi Limaye gives an overview of the biosimilar industry and projects for 2020.
Sep 29, 2016
By Pharmaceutical Technology Editors
Containing costs and improving compliance will be crucial to ensuring the growth of generic pharmaceuticals in the future, says Dilip Shah, CEO of Vision Consulting Group, in CPhI’s 2016 Annual Report, which will be formally issued at CPhI 2016 in Barcelona.
Sep 29, 2016
By Pharmaceutical Technology Editors
Alan Sheppard, Principal, Global Generics at IMS Health and CPhI expert panel member, discusses generic medicine opportunities in the 2016 CPhI Annual Industry Report.
native1_300x100
lorem ipsum